Johnson G Kenneth, Saeian Kia, Geenen Joseph E
Division of Gastroenterology and Hepatology, The Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 53226, USA.
Curr Gastroenterol Rep. 2006 Apr;8(2):147-55. doi: 10.1007/s11894-006-0011-y.
Primary sclerosing cholangitis (PSC) is an important cause of chronic liver disease. We review the management of PSC and report a 20-year follow-up of our initial 10 patients. This is the longest detailed follow-up of a group of PSC patients to date. We discuss the clinical course and results of endoscopic management in these patients and relate these data to management of PSC in general. We compare the actual survival of these patients to predicted survival scores based on the Mayo multicenter survival model. Although our patients presented with cholangitis, which typically reflects advanced stages of liver disease, their survival compares favorably with expected survival in unselected PSC patients. Endoscopic balloon dilation of PSC patients presenting with biliary strictures and cholangitis may have long-term benefit in addition to short-term symptomatic relief.
原发性硬化性胆管炎(PSC)是慢性肝病的重要病因。我们回顾了PSC的治疗情况,并报告了对最初10例患者进行的20年随访。这是迄今为止对一组PSC患者最长的详细随访。我们讨论了这些患者的临床病程及内镜治疗结果,并将这些数据与PSC的总体治疗相关联。我们将这些患者的实际生存率与基于梅奥多中心生存模型预测的生存分数进行比较。尽管我们的患者表现为胆管炎,这通常反映了肝病的晚期阶段,但他们的生存率与未选择的PSC患者的预期生存率相比更有利。对于出现胆管狭窄和胆管炎的PSC患者,内镜下球囊扩张除了能短期缓解症状外,可能还有长期益处。